Flockhart on the ascent of PGx

MIT Technology Review interviewed David Flockhart of IUPUI recently.  Here is a snip about the adoption of PGx testing:

TR: But the FDA has already approved a number of genetic tests to guide prescriptions. Aren’t doctors using them?

DF:
No…A major problem is
going to be educating physicians who are, as yet, relatively uneducated
about the availa­bility of genetic tests to guide some of their
prescribing decisions.

TR: How long will that take?

DF:
…The movement of these tests into the clinic will happen
gradually with fits and starts….Demand will kick in within a year or
two, as patients realize the power of these tests. That will be the
biggest driver…

–

Erika Jonietz. Getting Personal about Drugs. Genetic tests are poised to revolutionize prescription writing. MIT Technology Review. March/April 2006.

David Flockhart’s website at IUPUI.

March 13, 2006 | Filed Under education, pharmacogenomics-pharmacogenetics-pgx, predictions, thought-leaders 

Comments

One Response to “Flockhart on the ascent of PGx”

  1. Trackbacks on March 10th, 2010 2:47 am

Leave a Reply




You may use HTML tags in your comment. Please be patient, comments may take a while to post.

Subscribe without commenting